Jonathan Del Lockett
Known title: Chief Strategy OfficerCIK: 0001994792
Associated companies
Transaction History
| HIT | ▲ Buy | Grant | 50,000 | $0 | 5/20/2026 | View on chart |
| HIT | ▲ Buy | Grant | 7,000 | $0 | 8/15/2025 | View on chart |
| HIT | ▲ Buy | Grant | 50,000 | $0 | 5/20/2026 | View on chart |
| HIT | ▲ Buy | Grant | 7,000 | $0 | 8/15/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Health In Tech Unveils HitRix AI Platform and Raises FY26 Revenue Forecast
Health In Tech announced the launch of HitRix, an AI‑powered platform aimed at modernizing the nearly $1 trillion U.S. self‑funded health insurance market. The company also updated its full‑year 2026 revenue guidance to about $33 million. The move signals a shift toward technology‑driven solutions in the health‑insurance space and may influence investor perception of the company’s growth prospects.
Health In Tech Unveils HitRix AI Platform and Raises FY26 Revenue Forecast. Health In Tech announced the launch of HitRix, an AI‑powered platform aimed at modernizing the nearly $1 trillion U.S. self‑funded health insurance market. The company also updated its full‑year 2026 revenue guidance to about $33 million. The move signals a shift toward technology‑driven solutions in the health‑insurance space and may influence investor perception of the company’s growth prospects.